PD‐L1 showed positive expression in 26 of 48 AR‐NHL patients (54.2%) with available tissue specimens, while PD‐1 and PD‐L2 both showed positive expression rates of 50% (Figure 2A). Here, PDCD1LG2 is linked to non-Hodgkin lymphoma.